Figure 1.
Flow-chart of study selection.
Table 1.
Study and participant characteristics.
Figure 2.
Treatment network for the NMA.
Table 2.
Number of patients per treatment, naïve (averaged) clearance rates and clearance rates calculated with NMA.
Figure 3.
Absolute clearance rates (bars ± SE; left axis) and ranking according to the probability to be the best treatment (yellow dots; right axis) and the SUCRA score (yellow squares; right axis).
Table 3.
Efficacy of AK treatments for total patient clearance.
Table 4.
Efficacy of AK treatments for total patient clearance; all treatments relative to each other.